क्यूआर कोड

Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements

The combination of dabrafenib and trametinib is a well-established treatment for BRAF-mutated melanoma. However, the effectiveness of this approach may be hindered by the development of treatment-related pyrexia syndrome, which occurs in at least 50% of treated patients. Without appropriate interven...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Alia Thawer, Wilson H. Miller, Nancy Gregorio, Joël Claveau, Sudha Rajagopal, Kerry J. Savage, Xinni Song, Teresa M. Petrella, on behalf of the Canadian Working Group
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI AG 2021-09-01
श्रृंखला:Current Oncology
विषय:
melanoma
pyrexia
dabrafenib
trametinib
ऑनलाइन पहुंच:https://www.mdpi.com/1718-7729/28/5/304
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन